• Fjodorova M, Prapaiwongs P,  Petter O, Morella I,  Li Z, Hall J, Vinh NN, Davies S, Green J, Hall J, van den Bree M, Brambilla R, Li M. Direct  pathway bias and altered striatal neurogenesis in human iPSC models of 16p11.2 CNVs: Evidence from single-cell and functional analyses. bioRxiv 2025.02.26.640425; doi: https://doi.org/10.1101/2025.02.26.640425
  • Leone R, Zuglian C, Brambilla R, Morella I. Understanding copy number variations through their genes: a molecular view on 16p11.2 deletion and duplication syndromes. Front Pharmacol. 2024 Jun 14;15:1407865. doi: 10.3389/fphar.2024.1407865. PMID: 38948459; PMCID: PMC11211608.
  • Indrigo M, Morella I, Orellana D, d’Isa R, Papale A, Parra R, Gurgone A, Lecca D, Cavaccini A, Tigaret CM, Cagnotto A, Jones K, Brooks S, Ratto GM, Allen ND, Lelos MJ, Middei S, Giustetto M, Carta AR, Tonini R, Salmona M, Hall J, Thomas K, Brambilla R, Fasano S. Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2. EMBO Mol Med. 2023 Nov 8;15(11):e15984. doi: 10.15252/emmm.202215984. Epub 2023 Oct 4. PMID: 37792911; PMCID: PMC10630888.